Reports Q2 revenue $413.4M, consensus $685.98M. Reprots Q2 Adjusted EBITDA $19.3M, compared to $15.5M last year.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on PRVA:
- Privia Health Reports Second Quarter 2023 Financial Results
- Privia Health signs agreement to enter state of Washington
- Privia Health Announces Changes to Board of Directors
- Privia Health appoints David Wichmann, Pamela Kimmet to board of directors
- Privia Health to Report Second Quarter 2023 Results on Thursday, August 3